Literature DB >> 12095050

The role of TNF receptor and TNF superfamily molecules in organ transplantation.

Andrew B Adams1, Christian P Larsen, Thomas C Pearson, Kenneth A Newell.   

Abstract

The rapid increase in the number of molecules demonstrated to regulate immune responses has provided new opportunities for manipulation of the recipient immune response to transplanted organs. Molecules belonging to the TNF receptors and TNF superfamily are increasingly recognized as playing a major role in the regulation of immune responses to tumor, viral, and autoantigens. The mechanisms by which these molecules regulate immune responses are diverse. TNF receptor-related molecules have been shown to control the development of secondary lymphoid organs, affect the activation and survival of T cells and antigen presenting cells, and alter cytokine and chemokine production. An increasing amount of data suggest that some TNFR superfamily members are particularly important for the function of CD8+ T cells. Based on our current understanding of these molecules it seems highly likely that strategies that target selected TNFR/TNF superfamily molecules will be useful for controlling or preventing the rejection of transplanted organs and tissues.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12095050     DOI: 10.1034/j.1600-6143.2002.020104.x

Source DB:  PubMed          Journal:  Am J Transplant        ISSN: 1600-6135            Impact factor:   8.086


  12 in total

Review 1.  Update on hepatitis C virus-specific immunity.

Authors:  Donatella Ciuffreda; Arthur Y Kim
Journal:  Curr Opin HIV AIDS       Date:  2011-11       Impact factor: 4.283

Review 2.  Advances in small bowel transplantation.

Authors:  Alp Gürkan
Journal:  Turk J Surg       Date:  2017-09-01

3.  Selective blockade of herpesvirus entry mediator-B and T lymphocyte attenuator pathway ameliorates acute graft-versus-host reaction.

Authors:  Maria-Luisa del Rio; Nick D Jones; Leo Buhler; Paula Norris; Yasushi Shintani; Carl F Ware; Jose-Ignacio Rodriguez-Barbosa
Journal:  J Immunol       Date:  2012-04-06       Impact factor: 5.422

4.  CD8+ Th17 mediate costimulation blockade-resistant allograft rejection in T-bet-deficient mice.

Authors:  Bryna E Burrell; Keri Csencsits; Guanyi Lu; Svetlana Grabauskiene; D Keith Bishop
Journal:  J Immunol       Date:  2008-09-15       Impact factor: 5.422

5.  Costimulatory pathways in transplantation.

Authors:  Nina Pilat; Mohamed H Sayegh; Thomas Wekerle
Journal:  Semin Immunol       Date:  2011-05-26       Impact factor: 11.130

6.  Reduction of acute rejection by bone marrow mesenchymal stem cells during rat small bowel transplantation.

Authors:  Yang Yang; Hong-Li Song; Wen Zhang; Ben-Juan Wu; Nan-Nan Fu; Wei-Ping Zheng; Chong Dong; Chong Don; Zhong-Yang Shen
Journal:  PLoS One       Date:  2014-12-15       Impact factor: 3.240

7.  Heme oxygenase-1-transduced bone marrow mesenchymal stem cells in reducing acute rejection and improving small bowel transplantation outcomes in rats.

Authors:  Yang Yang; Hong Li Song; Wen Zhang; Ben Juan Wu; Nan Nan Fu; Chong Dong; Zhong Yang Shen
Journal:  Stem Cell Res Ther       Date:  2016-11-20       Impact factor: 6.832

8.  Role of B and T Lymphocyte Attenuator in Renal Transplant Recipients with Biopsy-Proven Acute Rejection.

Authors:  Zijie Wang; Haiwei Yang; Xuzhong Liu; Jingying Zhang; Zhijian Han; Jun Tao; Chunchun Zhao; Xiaobin Ju; Ruoyun Tan; Min Gu
Journal:  Med Sci Monit       Date:  2018-01-20

9.  CD160Ig fusion protein targets a novel costimulatory pathway and prolongs allograft survival.

Authors:  Francesca D'Addio; Takuya Ueno; Michael Clarkson; Baogong Zhu; Andrea Vergani; Gordon J Freeman; Mohamed H Sayegh; Mohammed Javeed I Ansari; Paolo Fiorina; Antje Habicht
Journal:  PLoS One       Date:  2013-04-04       Impact factor: 3.240

10.  Are different stoichiometries feasible for complexes between lymphotoxin-alpha and tumor necrosis factor receptor 1?

Authors:  Nahren Manuel Mascarenhas; Johannes Kästner
Journal:  BMC Struct Biol       Date:  2012-05-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.